학술논문

Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical
Document Type
Article
Source
In: eLife. (eLife, September 2021, 10)
Subject
Language
English
ISSN
2050084X